中国医药指南
中國醫藥指南
중국의약지남
CHINA MEDICINE GUIDE
2013年
21期
39-41
,共3页
熊少伟%刘贤明%伍友春%刘铮
熊少偉%劉賢明%伍友春%劉錚
웅소위%류현명%오우춘%류쟁
Roux-en-Y吻合术%2型糖尿病%胃癌%血糖%脂质代谢
Roux-en-Y吻閤術%2型糖尿病%胃癌%血糖%脂質代謝
Roux-en-Y문합술%2형당뇨병%위암%혈당%지질대사
Roux-en-Y anastomosis%Type 2 diabetes mellitus%Gastric carcinoma%Blood glucose%Lipid metabolism
目的探讨Roux-en-Y消化道重建术对胃癌合并2型糖尿病患者糖脂代谢的影响。方法回顾性分析2006年1月至2012年12月30例因胃癌合并2型糖尿病行胃癌根治、Roux-en-Y消化道重建术患者的临床资料,比较手术前后血糖血脂代谢指标的变化。结果与术前相比,术后FBG、2hPBG、HbA1c、TG、TC等指标均有明显下降,差异有统计学意义(P<0.05),术后患者BMI、HDL-C、LDL-C的变化差异无统计学意义(P>0.05)。结论 Roux-en-Y消化道重建术能较好地控制胃癌合并2型糖尿病患者的血糖和血脂,疗效确切可靠。
目的探討Roux-en-Y消化道重建術對胃癌閤併2型糖尿病患者糖脂代謝的影響。方法迴顧性分析2006年1月至2012年12月30例因胃癌閤併2型糖尿病行胃癌根治、Roux-en-Y消化道重建術患者的臨床資料,比較手術前後血糖血脂代謝指標的變化。結果與術前相比,術後FBG、2hPBG、HbA1c、TG、TC等指標均有明顯下降,差異有統計學意義(P<0.05),術後患者BMI、HDL-C、LDL-C的變化差異無統計學意義(P>0.05)。結論 Roux-en-Y消化道重建術能較好地控製胃癌閤併2型糖尿病患者的血糖和血脂,療效確切可靠。
목적탐토Roux-en-Y소화도중건술대위암합병2형당뇨병환자당지대사적영향。방법회고성분석2006년1월지2012년12월30례인위암합병2형당뇨병행위암근치、Roux-en-Y소화도중건술환자적림상자료,비교수술전후혈당혈지대사지표적변화。결과여술전상비,술후FBG、2hPBG、HbA1c、TG、TC등지표균유명현하강,차이유통계학의의(P<0.05),술후환자BMI、HDL-C、LDL-C적변화차이무통계학의의(P>0.05)。결론 Roux-en-Y소화도중건술능교호지공제위암합병2형당뇨병환자적혈당화혈지,료효학절가고。
Objective To elvaluate the effect of Roux-en-Y anastomosis on glucose and lipid metabolism in patients with gastric carcinoma and type 2 diabetes mellitus. Methods The clinica1 data of 30 patients with gastric carcinoma and type 2 diabetes mellitus accepted radical gastrectomy for gastric cancer and Roux-en-Y anastomosis were analyzed.Glucose and lipid metabolism indicators were compared before and after operation. Results After operation, FBG, 2hPBG, HbA1c, TG and TC levels decreased signiifcantly, the differences were statistically signiifcant(P<0.05), BMI, HDL-C and LDL-C levels were not signiifcantly changed before and after operation, the differences were not statistically signiifcant(P>0.05). Conclusion Roux-en-Y anastomosis can well control the level of blood glucose and lipid in patients with gastric carcinoma and type 2 diabetes mellitus,and it is quite effective and safe.